Worth reading
31Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 23 October 2026Scheduled Appointment DateEffective 27 November 2026. Formal decisions are scheduled to be made at the annual general meetings of shareholders of the Company and its consolidated subsidiaries scheduled for 27 November 2026, and at each company's subsequent Board of Directors meeting.
Whether the incumbent will remain in office (whether they will retain their position)
According to the table, all candidates of the Company and its consolidated subsidiaries will remain in the same positions they currently hold.
Directors after the change8Number
Shareholders’ meeting approvalRequired. Formal decisions are scheduled to be made at the annual general meetings of shareholders of the Company and its consolidated subsidiaries scheduled for 27 November 2026, and at each company's subsequent Board of Directors meeting.
| Item | Details |
|---|---|
| Resolution date | 23 October 2026 |
| Scheduled Appointment Date | Effective 27 November 2026. Formal decisions are scheduled to be made at the annual general meetings of shareholders of the Company and its consolidated subsidiaries scheduled for 27 November 2026, and at each company's subsequent Board of Directors meeting. |
| Whether the incumbent will remain in office | According to the table, all candidates of the Company and its consolidated subsidiaries will remain in the same positions they currently hold. |
| Number of directors after the change | Company: 8 directors (4 directors who are not Audit & Supervisory Committee members and 4 directors who are Audit & Supervisory Committee members), including 4 outside directors. |
| Subject to Approval by the General Meeting of Shareholders | Required. Formal decisions are scheduled to be made at the annual general meetings of shareholders of the Company and its consolidated subsidiaries scheduled for 27 November 2026, and at each company's subsequent Board of Directors meeting. |
Items this document does not state (16)
Date of departureName of appointeeAppointee's new positionAppointee's previous positionAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureReason for changeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.No specific reasons for the executive appointments were provided.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.